Literature DB >> 12620971

On noxious desmin: functional effects of a novel heterozygous desmin insertion mutation on the extrasarcomeric desmin cytoskeleton and mitochondria.

Rolf Schröder1, Bertrand Goudeau, Monique Casteras Simon, Dirk Fischer, Thomas Eggermann, Christoph S Clemen, Zhenlin Li, Jens Reimann, Zhigang Xue, Sabine Rudnik-Schöneborn, Klaus Zerres, Peter F M van der Ven, Dieter O Fürst, Wolfram S Kunz, Patrick Vicart.   

Abstract

Recent studies in desmin (-/-) mice have shown that the targeted ablation of desmin leads to pathological changes of the extrasarcomeric intermediate filament cytoskeleton, as well as structural and functional abnormalities of mitochondria in striated muscle. Here, we report on a novel heterozygous single adenine insertion mutation (c.5141_5143insA) in a 40-year-old patient with a distal myopathy. The insertion mutation leads to a frameshift and a truncated desmin (K239fs242). Using transfection studies in SW13 and BHK21 cells, we show that the K239fsX242 desmin mutant is incapable of forming a desmin intermediate filament network. Furthermore, it induces the collapse of a pre-existing desmin cytoskeleton, alters the subcellular distribution of mitochondria and leads to abnormal cytoplasmic protein aggregates reminiscent of desmin-immunoreactive granulofilamentous material seen in the ultrastructural analysis of the patient's muscle. Analysis of mitochondrial function in isolated saponin-permeablized skeletal muscle fibres from our patient showed decreased maximal rates of respiration with the NAD-dependent substrate combination glutamate and malate, as well as a higher amytal sensitivity of respiration, indicating an in vivo inhibition of complex I activity. Our findings suggest that the heterozygous K239fsX242 desmin insertion mutation has a dominant negative effect on the polymerization process of desmin intermediate filaments and affects not only the subcellular distribution, but also biochemical properties of mitochondria in diseased human skeletal muscle. As a consequence, the intermediate filament pathology-induced mitochondrial dysfunction may contribute to the degeneration/regeneration process leading to progressive muscle dysfunction in human desminopathies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12620971     DOI: 10.1093/hmg/ddg060

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  28 in total

1.  Cardiac conduction disturbances and differential effects on atrial and ventricular electrophysiological properties in desmin deficient mice.

Authors:  Jan Wilko Schrickel; Florian Stöckigt; Wieslaw Krzyzak; Denise Paulin; Zhenlin Li; Indra Lübkemeier; Bernd Fleischmann; Philipp Sasse; Markus Linhart; Thorsten Lewalter; Georg Nickenig; Lars Lickfett; Rolf Schröder; Christoph Stephan Clemen
Journal:  J Interv Card Electrophysiol       Date:  2010-08       Impact factor: 1.900

2.  A mutation in the dimerization domain of filamin c causes a novel type of autosomal dominant myofibrillar myopathy.

Authors:  Matthias Vorgerd; Peter F M van der Ven; Vera Bruchertseifer; Thomas Löwe; Rudolf A Kley; Rolf Schröder; Hanns Lochmüller; Mirko Himmel; Katrin Koehler; Dieter O Fürst; Angela Huebner
Journal:  Am J Hum Genet       Date:  2005-05-31       Impact factor: 11.025

Review 3.  Molecular insights into cardiomyopathies associated with desmin (DES) mutations.

Authors:  Andreas Brodehl; Anna Gaertner-Rommel; Hendrik Milting
Journal:  Biophys Rev       Date:  2018-06-20

Review 4.  Desmin-related cardiomyopathy: an unfolding story.

Authors:  Patrick M McLendon; Jeffrey Robbins
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-07-22       Impact factor: 4.733

5.  Intermediate filament diseases: desminopathy.

Authors:  Lev G Goldfarb; Montse Olivé; Patrick Vicart; Hans H Goebel
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

6.  Disruption of desmin-mitochondrial architecture in patients with regurgitant mitral valves and preserved ventricular function.

Authors:  Mustafa I Ahmed; Jason L Guichard; Rajasekaran Namakkal Soorappan; Shama Ahmad; Nithya Mariappan; Silvio Litovsky; Himanshu Gupta; Steven G Lloyd; Thomas S Denney; Pamela Cox Powell; Inmaculada Aban; James Collawn; James E Davies; David C McGiffin; Louis J Dell'Italia
Journal:  J Thorac Cardiovasc Surg       Date:  2016-06-25       Impact factor: 5.209

7.  Distinct muscle imaging patterns in myofibrillar myopathies.

Authors:  D Fischer; R A Kley; K Strach; C Meyer; T Sommer; K Eger; A Rolfs; W Meyer; A Pou; J Pradas; C M Heyer; A Grossmann; A Huebner; W Kress; J Reimann; R Schröder; B Eymard; M Fardeau; B Udd; L Goldfarb; M Vorgerd; M Olivé
Journal:  Neurology       Date:  2008-09-02       Impact factor: 9.910

Review 8.  Valosin-containing protein disease: inclusion body myopathy with Paget's disease of the bone and fronto-temporal dementia.

Authors:  Conrad C Weihl; Alan Pestronk; Virginia E Kimonis
Journal:  Neuromuscul Disord       Date:  2009-04-19       Impact factor: 4.296

Review 9.  Tragedy in a heartbeat: malfunctioning desmin causes skeletal and cardiac muscle disease.

Authors:  Lev G Goldfarb; Marinos C Dalakas
Journal:  J Clin Invest       Date:  2009-07-01       Impact factor: 14.808

Review 10.  The role of heat shock proteins and co-chaperones in heart failure.

Authors:  Mark J Ranek; Marisa J Stachowski; Jonathan A Kirk; Monte S Willis
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2018-01-19       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.